This document provides an overview of Variola Major (Smallpox) including its virology, history, epidemiology, symptoms, transmission, treatment and prevention. It discusses computational approaches that have been used to model and simulate smallpox outbreaks and response strategies. The document also notes that smallpox is considered a potential bioterrorism agent and outlines mitigation and control efforts that would be implemented in response to an attack.
2. Outline
Background
Virology
History and Epidemiology of Smallpox
Symptoms
Transmission
Treatment
Mitigation and Control
Computational approaches to Smallpox Containment
Bioterrorism threat
3. Background
Also known as Smallpox
Caused by a Variola major, a virus belonging to the family of
poxviridae
Very infectious and often leave scars and blindness
Fatality rate of about 30%, can get to 50% in densely populated areas
Incubation period is about 12 days
4. Virology of Variola
Belongs to the genus orthopoxvirus,
family poxviridae and subfamily
chordopoxvirinae
Single, linear, double-stranded DNA
Molecules
Replicates in cell cytoplasm
Measure about 300 x 200 nm in size
Shaped like bricks
5. History
First appeared in Egypt in 10,000 BC
6th Century – Increased trade with China and Korea introduces smallpox into Japan.
7th Century – Arab expansion spreads smallpox into northern Africa, Spain, and
Portugal.
11th Century – Crusades further spread smallpox in Europe.
15th Century – Portuguese occupation introduces smallpox into part of western Africa.
16th Century – European colonization and the African slave trade import smallpox into
the Caribbean and Central and South America.
17th Century – European colonization imports smallpox into North America.
18th Century – Exploration by Great Britain introduces smallpox into Australia.
6. Epidemiology
Up to 500 million persons died from smallpox in the 20th
century
Reduced the population of Cook Inlet in Southcentral
Alaska by half in 1830
Killed half of Cherokee Indian population in 1738
Other introductions: (Facilitated Spanish conquest)
Caribbeans 1507
Mexico 1520
Peru 1524
Brazil 1555
Total death: up to 1billion
Last known case: 1975 (Bangladesh) (1949: LO in the USA)
May 8, 1980: WHO declared the world free of Smallpox
7. Symptoms
Early symptoms include:
High fever
Head and body aches
Sometimes vomiting
Rashes (small red spots) on the tongue and in the mouth. Spots change into sores
that break open and spread large amounts of the virus into the mouth and throat.
Rashes spreads to other parts of the body, forming sores
The sores will later become pustules (sharply raised, usually round and firm to the
touch, like peas under the skin).
Rashes and scabs disappear after about 4 weeks
8. Transmission
Airborne Route:
Aerosol
Person – to- person
Hospital outbreaks from coughing patients
Infectious material
Saliva
Vesicular Fluids
Scabs
Urine
Conjunctival Fluid
Blood
May cross the placenta
Does not occur through animals or insect
9. Treatment and Prevention
Treatment
Supportive care (No treatment has proven
effective)
Use of experimental antiviral (Cidofovir)
Prophylaxis
Vaccination (Most effective when given
within 3days of exposure)
Has serious side effects (some life-
threatening)
10. Smallpox Eradication Statue
“The eradication of smallpox shows that with
strong mutual resolve, teamwork and an
international spirit of solidarity, ambitious global
public health goals can be attained,"
Dr Margaret Chan, Director-General,
WHO (2010)
Erected on 17th May, 2010 at WHO HQ to
commemorates 30th anniversary of Smallpox
eradication
11. Computational Approaches to Smallpox
Containment
Burke Et al created a model to simulate response scenarios in an event
of smallpox bioterrorism attack
Created different scenarios, population level, response level
Setting up a computational model will help study effects of a
potential outbreak and state of preparedness
Parameters:
Populations size, density, age, georgical location of health institutions,
Case Isolation and Contact Tracing (Martin Eichner, 2003)
12.
13. Smallpox and Bioterrorism
Considered a very potential bioterrorism weapon, second to anthrax
“Class A Bioterrorist Threats” (CDC, WHO)
Could be very devastating; depreciated immunity against VM in the population
British army used smallpox as a biological weapon against Pontiac Indians in 1763
(Phillip Ranlet, 2000)
Impacts of an attack on a particular on a prticular geographic location maybe felt
globally. “Human mobility and the worldwide impact of intentional localized
highly pathogenic virus release” (Goncalves B. et al, 2014)
14. Mitigation and Control (of an eventual attack)!
Emergency Response Preparedness: 3 major levels:
Community-based planning
Build Community Partnership, Identify Resources, Help People with Functional, Language or
Cognitive needs
Public Heath Response Activities
Isolate case, surveillance, vaccination, information mgt and epidemiological investigation
Health Care Facility response Activities
Protection of staff, preventing further spread
Modelling situations of eventual Bioterrorism attack and how response
will be coordinated.
Need for development of:
a vaccine without significant adverse effects
15. References
History of Global Smallpox outbreaks:
https://www.cdc.gov/smallpox/index.html
Whitley R. J: Smallpox: A Potential Agent of Bioterrorism. Antiviral
Research. Elsevier:2003, Vol.57. Iss 1-2
Bioterrorism planning for Smallpox:
https://www.cdc.gov/smallpox/bioterrorism-response-
planning/index.html
Thomson Prentice; Smallpox, Bioterrorism and WHO; WHO publications,
Geneva, 2007
Burke D.S; Epstein J.M et al: Individual-based Computational Modelling of
Smallpox Epidemic Control Strategies. Journal of the Society for Academic
Emergency Medicine, 2006
Editor's Notes
replicate in the cytoplasm of the cell rather than in the nucleus. In order to replicate, poxviruses produce a variety of specialized proteins not produced by other DNA viruses,